...
首页> 外文期刊>Molecular Genetics & Genomic Medicine >MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form
【24h】

MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form

机译:myh2肌病,一个新案例扩展了隐性形式的临床和病理谱

获取原文

摘要

Background Hereditary myosin myopathies are a group of rare muscle disorders, caused by mutations in genes encoding for skeletal myosin heavy chains (MyHCs). MyHCIIa is encoded by MYH2 and is expressed in fast type 2A and 2B muscle fibers. MYH2 mutations are responsible for an autosomal dominant (AD) progressive myopathy, characterized by the presence of rimmed vacuoles and by a reduction in the number and size of type 2A fibers, and a recessive early onset myopathy characterized by complete loss of type 2A fibers. Recently, a patient with a homozygous mutation but presenting a dominant phenotype has been reported. Methods The patient was examined thoroughly and two muscle biopsies were performed through the years. NGS followed by confirmation in Sanger sequencing was used to identify the genetic cause. Results We describe the second case presenting with late‐onset ophthalmoparesis, ptosis, diffuse muscle weakness, and histopathological features typical for AD forms but with a recessive MYH2 genotype. Conclusion This report contributes to expand the clinical and genetic spectrum of MYH2 myopathies and to increase the awareness of these very rare diseases.
机译:背景技术遗传性肌苷肌病是一组稀有肌肉疾病,由编码骨骼肌重链(MYHCS)的基因突变引起。 MyHCIIa由MyH2编码,在快速型2a和2b肌纤维中表达。 MyH2突变是对常染色体显性(Ad)渐进性肌病的原因,其特征在于,通过叠层的液压耐水质的存在和2A型纤维的数量和尺寸的减少,以及通过完全损失2A型纤维的缺陷的隐性早期发病肌病。最近,已经报道了具有纯合的突变但呈现显性表型的患者。方法彻底检查患者,多年来进行两种肌肉活检。 NGS随后用Sanger测序确认用于鉴定遗传原因。结果我们描述了第二种病例,其具有晚期发作眼科,脑病,弥漫性肌肉弱点和典型的组织病理学特征,典型的广告形式,但具有隐性MyH2基因型。结论本报告有助于扩大Myh2肌病的临床和遗传谱,并提高这些非常罕见的疾病的认识。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号